Aug 28, 2026
FDA Approves Stelara for Pediatric Ulcerative Colitis
The FDA approved ustekinumab (Stelara) on August 28, 2026 for the treatment of moderately to severely active ulcerative colitis in pediatric patients aged 2 years and older, making it the first non-TNF biologic approved for pediatric IBD.
1 source
00